生物活性 | |||
---|---|---|---|
描述 | Abacavir is a competitive nucleoside reverse transcriptase inhibitor with oral activity. It inhibits HIV replication and displays anticancer potential in prostate cancer cell lines. Additionally, Abacavir can cross the blood-brain barrier and inhibit telomerase activity[1].[2].[3]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02868580 | Amyotrophic Lateral Sclerosis | Phase 2 | Active, not recruiting | June 2018 | Australia, New South Wales ... 展开 >> Macquarie Neurology North Ryde, New South Wales, Australia, 2109 Westmead Hospital Parramatta, New South Wales, Australia, 2150 Brain and Mind Centre Sydney, New South Wales, Australia, 2050 Australia, Victoria Calvary Health Care Bethlehem Caulfield South, Victoria, Australia, 3162 收起 << |
NCT00085943 | HIV Infection ... 展开 >> Infection, Human Immunodeficiency Virus 收起 << | Phase 3 | Completed | - | - |
NCT00005017 | HIV Infections | Phase 4 | Unknown | - | United States, North Carolina ... 展开 >> Jaime Hernandez Research Triangle Park, North Carolina, United States, 27709 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.49mL 0.70mL 0.35mL |
17.46mL 3.49mL 1.75mL |
34.92mL 6.98mL 3.49mL |
参考文献 |
---|